Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Amifampridine is mainly used to treat many rare muscle diseases. In the United States, aminopyridine is being studied for the treatment of Lambert-Eaton myasmus syndrome (LEMS). Amifampridine is also used to treat many congenital myasthenia syndromes, particularly those with defects in choline acetyltransferase, downstream kinase 7, and any type of defects leading to "fast track" defects.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Amifampridine is mainly used to treat many rare muscle diseases. In the United States, aminopyridine is being studied for the treatment of Lambert-Eaton myasmus syndrome (LEMS). Amifampridine is also used to treat many congenital myasthenia syndromes, particularly those with defects in choline acetyltransferase, downstream kinase 7, and any type of defects leading to "fast track" defects. |
Synonyms | BRN0110232, 3,6-DAP, SC10, BRN 0110232, BRN-0110232, NSC 521760 |
Molecular Weight | 207.12 |
Formula | C5H10N3O4P |
CAS No. | 446254-47-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Amifampridine phosphate 446254-47-3 NSC521760 Amifampridine Phosphate NSC-521760 BRN0110232 3,6-DAP SC10 BRN 0110232 SC-10 SC 10 BRN-0110232 NSC 521760 inhibitor inhibit